(16 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{{Tongji_China/Head_N_Prefix}} | {{Tongji_China/Head_N_Prefix}} | ||
− | + | {{Tongji_China/userDefault}} | |
− | + | ||
− | + | ||
{{Tongji_China/Head_N_Suffix}} | {{Tongji_China/Head_N_Suffix}} | ||
{{Tongji_China/Header_N}} | {{Tongji_China/Header_N}} | ||
Line 13: | Line 11: | ||
<body> | <body> | ||
<div class="background"> | <div class="background"> | ||
+ | <div class="content"> | ||
+ | <div class="title">Achievement</div> | ||
+ | <div class="logoPicture"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/5/50/T--Tongji_China--picture-judgingform-0.png" width="15%" height="25%" /> | ||
+ | </div> | ||
+ | <div class="title_2">Judging Form</div> | ||
<div class="judgeTitle" style="margin-top:auto;"> | <div class="judgeTitle" style="margin-top:auto;"> | ||
− | Bronze medal | + | <br>Bronze medal |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
Line 20: | Line 24: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
− | + | We've successfully registered and will attend the Giant Jamboree.<br><br> | |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
Line 26: | Line 30: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
− | We have clear attributions.<br> | + | We have clear attributions. See more details at<br> |
− | <a href="https://2018.igem.org/Team:Tongji_China/Attributions">https://2018.igem.org/Team:Tongji_China/Attributions</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Attributions">https://2018.igem.org/Team:Tongji_China/Attributions</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
Line 33: | Line 37: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
− | + | We've successfully participated in the 2018 InterLab Study.<br> | |
− | <a href="https://2018.igem.org/Team:Tongji_China/InterLab">https://2018.igem.org/Team:Tongji_China/InterLab</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/InterLab">https://2018.igem.org/Team:Tongji_China/InterLab</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle"> | <div class="judgeTitle"> | ||
Line 43: | Line 47: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
− | + | We've made several new BioBricks relating to T3SS and cancer immunotherapy and successfully submitted them. The numbers of them are<br> | |
+ | <a href="https://2018.igem.org/Team:Tongji_China/Part">https://2018.igem.org/Team:Tongji_China/Part</a><br><br> | ||
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
Line 49: | Line 54: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
− | We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to | + | We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SKLMT-China and SJTU-BioX-Shanghai.<br> |
− | <a href="https://2018.igem.org/Team:Tongji_China/Collaborations">https://2018.igem.org/Team:Tongji_China/Collaborations</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Collaborations">https://2018.igem.org/Team:Tongji_China/Collaborations</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
Line 56: | Line 61: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
− | We’ve done education work in high school and | + | We’ve done education work in high school and some surveys according to our projects.<br> |
− | <a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle"> | <div class="judgeTitle"> | ||
Line 66: | Line 71: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
− | + | We've done survey in range of society, hospitals and campus. According to the attitudes of the public and the advice from doctors and teachers, we've made further plans for our project. Besides, we've visited the Roche Co. and got the idea of our therapeutic product. | |
<br> | <br> | ||
− | <a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
Line 74: | Line 79: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
− | + | We've made a model of the antigen and SNVs.<br> | |
− | <a href="https://2018.igem.org/Team:Tongji_China/Model">https://2018.igem.org/Team:Tongji_China/Model</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Model">https://2018.igem.org/Team:Tongji_China/Model</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
Line 81: | Line 86: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
− | + | We've done a series of experiments to make sure that the antigens can be transferred into APCs and thus trigger the immunoreaction.<br> | |
− | <a href="https://2018.igem.org/Team:Tongji_China/Demonstrate">https://2018.igem.org/Team:Tongji_China/Demonstrate</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Demonstrate">https://2018.igem.org/Team:Tongji_China/Demonstrate</a><br><br> |
</div> | </div> | ||
</div> | </div> | ||
+ | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
{{Tongji_China/Footer_N}} | {{Tongji_China/Footer_N}} |
Latest revision as of 12:20, 17 October 2018
Achievement
Judging Form
Bronze medal
Registration and Jamboree Attendance
We've successfully registered and will attend the Giant Jamboree.
Attributions
We have clear attributions. See more details at
https://2018.igem.org/Team:Tongji_China/Attributions
https://2018.igem.org/Team:Tongji_China/Attributions
Characterization
We've successfully participated in the 2018 InterLab Study.
https://2018.igem.org/Team:Tongji_China/InterLab
https://2018.igem.org/Team:Tongji_China/InterLab
Silver medal
Validated Part
We've made several new BioBricks relating to T3SS and cancer immunotherapy and successfully submitted them. The numbers of them are
https://2018.igem.org/Team:Tongji_China/Part
https://2018.igem.org/Team:Tongji_China/Part
Collaboration
We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SKLMT-China and SJTU-BioX-Shanghai.
https://2018.igem.org/Team:Tongji_China/Collaborations
https://2018.igem.org/Team:Tongji_China/Collaborations
Human Practices
We’ve done education work in high school and some surveys according to our projects.
https://2018.igem.org/Team:Tongji_China/Human_Practices
https://2018.igem.org/Team:Tongji_China/Human_Practices
Gold medal
Integrated Human Practices
We've done survey in range of society, hospitals and campus. According to the attitudes of the public and the advice from doctors and teachers, we've made further plans for our project. Besides, we've visited the Roche Co. and got the idea of our therapeutic product.
https://2018.igem.org/Team:Tongji_China/Human_Practices
https://2018.igem.org/Team:Tongji_China/Human_Practices
Model Your Project
Demonstration of Your Work
We've done a series of experiments to make sure that the antigens can be transferred into APCs and thus trigger the immunoreaction.
https://2018.igem.org/Team:Tongji_China/Demonstrate
https://2018.igem.org/Team:Tongji_China/Demonstrate